LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio

    01/03/2023
    NEWS RELEASE

    Brussels, 1 March 2023 – EuropaBio is pleased to announce that Vlad Olteanu joins EuropaBio’s Healthcare Biotechnology team as Healthcare Public Affairs Director.

    Vlad is a Belgian and Romanian national who studied mathematics, economics, law and political sciences in Romania, Belgium, France and the United Kingdom. Vlad has worked for many years with top-tier law firms, global corporations and consultancies delivering legal advice, public affairs strategy and its implementation for actors in public (including the European Commission, the World Bank, EU Member States) and private sector.

    Speaking about his appointment, Vlad said: “I am delighted to take on the role of Healthcare Public Affairs Director at EuropaBio at a time of significant transformation for the industry. I look forward to working with a great team and members to ensure that biotechnology plays a key role in achieving a more sustainable and healthier society within Europe and beyond.”

    Claire Skentelbery, Director General of EuropaBio commented: “Vlad brings a fantastic public affairs track record across sectors and countries to EuropaBio and he has a warm welcome into the team, ready to address the most significant legislative changes in healthcare biotechnology in a generation.”

    Vlad will take on the new role with immediate effect.

    Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more
    12/05/2026

    ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act


    Read more
    08/05/2026

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Read more

    Important links

    • Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force
    • ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.